Beijing Kexing Zhongwei Biological Technology

Beijing Kexing Zhongwei Biological Technology, commonly known as Sinovac Life Sciences, is a leading biopharmaceutical company based in China that specializes in the research, development, and manufacturing of vaccines. As a key subsidiary of Sinovac Biotech, the company rose to global prominence with the development of CoronaVac, an inactivated COVID-19 vaccine that has been administered to billions of people worldwide. The company's portfolio also includes established vaccines for Hepatitis A, Enterovirus 71, and seasonal influenza, supported by large-scale, high-containment manufacturing facilities. Sinovac Life Sciences continues to focus on emerging infectious diseases and expanding its global footprint through strategic partnerships and international clinical trials.